Scott Savage

Scott Savage is currently the Senior Director of CMC at Neuron23 since January 2021. Prior to this role, Scott was the Director of CMC at pH Pharma Inc. from October 2017 to January 2021. Before that, Scott worked at Genentech from January 2003 to October 2017, holding various roles including Prinicipal Scientific Researcher & Project Team Leader, Process Chemistry. Scott obtained a degree in biochemistry from California Polytechnic State University-San Luis Obispo in 2001 and continued their education at UC Irvine from 2001 to 2003.